Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ip Group (IPO) Share Price

Price 50.40p on 05-03-2026 at 05:12:30
Change 0.00p 0%
Buy 53.70p
Sell 50.40p
Last Trade: Buy 1,079,518.00 at 50.40p
Day's Volume: 0
Last Close: 50.40p
Open: 0.00p
ISIN: GB00B128J450
Day's Range 0.00p - 0.00p
52wk Range: 34.50p - 66.00p
Market Capitalisation: £445.25m
VWAP: 0.00p
Shares in Issue: 883.43m

Ip Group (IPO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,079,518 50.40p Suspected BUY Trade
16:35:16 - 04-Mar-26
Buy* 730 50.50p SI Trade
16:29:29 - 04-Mar-26
Buy* 6,124 50.40p Automatic Execution
16:29:06 - 04-Mar-26
Buy* 1,900 50.40p Automatic Execution
16:29:06 - 04-Mar-26
Sell* 1,569 50.20p Automatic Execution
16:17:44 - 04-Mar-26
Sell* 207 50.20p Automatic Execution
16:17:44 - 04-Mar-26
Sell* 7 50.20p Automatic Execution
16:16:08 - 04-Mar-26
Sell* 226 50.30p Automatic Execution
16:14:52 - 04-Mar-26
Sell* 2,679 50.30p Automatic Execution
16:14:52 - 04-Mar-26
Sell* 318 50.30p Automatic Execution
16:14:52 - 04-Mar-26
See more Ip Group trades

Ip Group (IPO) Share Price History

Time period:
to
Date Open High Low Close Volume
5th Mar 2026 (Thu) 50.40 50.40 50.40 50.40 0
4th Mar 2026 (Wed) 50.00 50.60 48.80 50.40 2,699,039
3rd Mar 2026 (Tue) 51.90 51.90 48.55 49.75 10,634,378
2nd Mar 2026 (Mon) 58.50 58.50 51.80 52.80 3,535,532
27th Feb 2026 (Fri) 55.20 58.40 55.20 57.00 7,627,871
26th Feb 2026 (Thu) 57.10 57.60 56.50 57.50 1,006,160
25th Feb 2026 (Wed) 56.90 57.50 56.50 57.30 948,781
24th Feb 2026 (Tue) 56.80 57.00 55.50 56.00 1,859,013
23rd Feb 2026 (Mon) 57.90 58.30 56.60 56.70 2,580,137
20th Feb 2026 (Fri) 57.50 58.10 57.30 58.00 1,605,213
19th Feb 2026 (Thu) 58.40 58.40 57.60 57.60 2,790,181
18th Feb 2026 (Wed) 60.00 60.00 57.70 58.00 990,877
17th Feb 2026 (Tue) 57.90 58.20 57.60 58.00 771,731
16th Feb 2026 (Mon) 57.70 59.00 57.70 57.80 533,049
13th Feb 2026 (Fri) 57.70 58.90 57.70 58.40 1,047,611
12th Feb 2026 (Thu) 58.50 60.00 58.30 58.40 772,973
11th Feb 2026 (Wed) 58.60 59.60 57.70 59.40 1,512,245
10th Feb 2026 (Tue) 61.00 61.00 58.00 59.20 1,152,422
9th Feb 2026 (Mon) 61.40 61.40 57.70 58.30 2,068,239
6th Feb 2026 (Fri) 58.00 58.50 57.70 57.70 1,514,833
5th Feb 2026 (Thu) 60.00 60.00 57.70 58.00 5,118,354
See more Ip Group price history

Ip Group (IPO) Regulatory News

Date Source Headline
4th Mar 2026 7:00 am RNS-R Portfolio company Oxa raises $103m in Series D
26th Feb 2026 2:53 pm RNS Holding(s) in Company
26th Feb 2026 9:30 am RNS Holding(s) in Company
25th Feb 2026 5:51 pm RNS Holding(s) in Company
11th Feb 2026 9:01 am RNS-R Microbiotica announces positive P1b trial results
30th Jan 2026 7:00 am RNS Holding(s) in Company
29th Jan 2026 7:00 am RNS Holding(s) in Company
20th Jan 2026 12:36 pm RNS Holding(s) in Company
14th Jan 2026 7:00 am RNS Directorate change
14th Jan 2026 7:00 am RNS Holding(s) in Company
See more Ip Group regulatory news

Ip Group (IPO) Share News

IP Group commits USD35 million to autonomous driving firm Oxa

4th Mar 2026 11:08

(Alliance News) - Shares in IP Group PLC rose on Wednesday, as the firm noted its participation in a USD103 million fundraise by Oxa Autonomy Ltd. Read More

IN BRIEF: Prudential chair-designate Flint to join insurer on March 4

13th Feb 2026 16:36

Prudential PLC - London-based insurer - Confirms Douglas Flint's appointment as a non-executive director and chair-designate will become effective on March 4. As previously announced, Flint will succeed Shriti Vadera as chair after the annual general meeting on May 28, when Vadera will leave the board. Flint, who has previously chaired Asia-focused lender HSBC Holdings PLC, currently holds the same post at asset manager Aberdeen Group PLC and intellectual property commercialisation firm IP Group PLC. Read More

IP Group portfolio firm Microbiotica reports positive trial results

11th Feb 2026 12:06

(Alliance News) - IP Group PLC on Wednesday said portfolio company Microbiotica Ltd has announced positive results from a phase 1b first-in-human trail of MB310 in ulcerative colitis patients. Read More

Prudential names former HSBC veteran Flint as next chair

14th Jan 2026 06:54

(Alliance News) - Prudential PLC on Wednesday said it has named Douglas Flint as its next chair, replacing Shriti Vadera, who will round off a roughly five-year stint in the position in May. Read More

IN BRIEF: IP Group notes investee Pulmocide terminating phase 3 study

7th Jan 2026 15:20

IP Group PLC - London-based intellectual property commercialisation firm - Notes that portfolio company Pulmocide announced the termination of the Opera-T phase 3 study for opelconazole in refractory invasive pulmonary aspergillosis, a severe fungal infection of the lungs. Opelconazole is an experimental antifungal drug. IP has a 12.0% holding in Pulmocide valued at GBP28.1 million. Pulmocide, a biopharmaceutical firm, will conduct a thorough review of the unblinded data from the trial to determine potential next steps for the programme. IP adds that it expects to "significantly" reduce the carrying value of the asset and conduct further work as part of the year end process to fully gauge the appropriate level of its adjustment. IP says it "benefits from a strong pipeline of new and maturing companies, as well as a number of valuable licences, and remains confident of delivering meaningful returns for shareholders over the medium term." Read More

See more Ip Group news
FTSE 100 Latest
Value10,567.65
Change83.52

Login to your account

Forgot Password?

Not Registered